StockNews.AI
OGN
StockNews.AI
91 days

OGN INVESTIGATION: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Firm

1. Robbins Geller investigating Organon for potential securities law violations. 2. Concerns over misleading statements and failure to disclose material information. 3. Organon cut its dividend by approximately 90% on May 1, 2025. 4. Following the cut, Organon's stock price fell over 28%. 5. Robbins Geller is a leading firm in securities fraud litigation.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The investigation may uncover significant liabilities, impacting investor confidence similar to past securities fraud cases. Historical examples, such as Enron, show how investigations can severely impact stock prices.

How important is it?

The article discusses significant legal issues that could lead to substantial financial consequences for Organon, making it highly relevant to investors.

Why Short Term?

The immediate impact from ongoing investigations often leads to quick market reactions, as seen with other companies facing similar scrutiny.

Related Companies

SAN DIEGO, May 20, 2025

PRNewswire -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Organon & Co. (NYSE: OGN) focused on whether Organon as well as certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors.

If you have information that could assist in the Organon investigation or if you are an Organon investor who suffered a loss and would like to learn more, you can provide your information here.

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

THE COMPANY:

Organon is a global healthcare company with a primary focus on improving the health of women.

THE REVELATION:

On May 1, 2025, Organon revealed that it was cutting its dividend by approximately 90%. Following this news, the price of Organon stock fell more than 28%.

ABOUT ROBBINS GELLER:

Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.

Contact:

Robbins Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected]

SOURCE Robbins Geller Rudman & Dowd LLP

Related News